Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
Background: Nonselective beta-blockers (NSBBs) can reduce the incidence or mortality of certain types of cancers, and NSBBs exert a protective effect on hepatocellular carcinoma (HCC) in patients with cirrhosis. However, the potential preventive effect of NSBBs has not yet been investigated in patie...
Saved in:
Main Authors: | He-Yun Cheng (Author), Hsiu C. Lin (Author), Hsiu L. Lin (Author), Yow S. Uang (Author), Joseph J. Keller (Author), Li H. Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association Between Acid-Suppressive Agents' Use and Risk of Hepatocellular Carcinoma
by: Hsiu C. Lin, et al.
Published: (2020) -
Optimal resting heart rate and ascites‐related death in patients with cirrhosis and ascites using nonselective beta‐blockers (ORCA)
by: Warunee Mingpun, et al.
Published: (2024) -
Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
by: Xinyi He, et al.
Published: (2023) -
Association between statin use and the risk of gout in patients with hyperlipidemia: A population-based cohort study
by: Guan-Ling Lin, et al.
Published: (2023) -
Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
by: William Dungan MD, et al.
Published: (2022)